A Study of SB751689 in Japanese Postmenopausal Women
Status:
Completed
Trial end date:
2006-12-12
Target enrollment:
Participant gender:
Summary
To investigate the safety and tolerability, PK and PD of SB751689 following single and 5-day
multiple oral doses of 100, 200, and 400 mg in Japanese postmenopausal subjects.